Literature DB >> 11684694

Phosphorylation of MEK1 by cdk5/p35 down-regulates the mitogen-activated protein kinase pathway.

Pushkar Sharma1, Monica Sharma, Niranjana D Amin, Ram K Sihag, Philip Grant, Natalie Ahn, Ashok B Kulkarni, Harish C Pant.   

Abstract

Cyclin-dependent protein kinase 5 (cdk5), a member of the cdk family, is active mainly in postmitotic cells and plays important roles in neuronal development and migration, neurite outgrowth, and synaptic transmission. In this study we investigated the relationship between cdk5 activity and regulation of the mitogen-activated protein (MAP) kinase pathway. We report that cdk5 phosphorylates the MAP kinase kinase-1 (MEK1) in vivo as well as the Ras-activated MEK1 in vitro. The phosphorylation of MEK1 by cdk5 resulted in inhibition of MEK1 catalytic activity and the phosphorylation of extracellular signal-regulated kinase (ERK) 1/2. In p35 (cdk5 activator) -/- mice, which lack appreciable cdk5 activity, we observed an increase in the phosphorylation of NF-M subunit of neurofilament proteins that correlated with an up-regulation of MEK1 and ERK1/2 activity. The activity of a constitutively active MEK1 with threonine 286 mutated to alanine (within a TPXK cdk5 phosphorylation motif in the proline-rich domain) was not affected by cdk5 phosphorylation, suggesting that Thr286 might be the cdk5/p35 phosphorylation-dependent regulatory site. These findings support the hypothesis that cdk5 and the MAP kinase pathway cross-talk in the regulation of neuronal functions. Moreover, these data and the recent studies of Harada et al. (Harada, T., Morooka, T., Ogawa, S., and Nishida, E. (2001) Nat. Cell Biol. 3, 453-459) have prompted us to propose a model for feedback down-regulation of the MAP kinase signal cascade by cdk5 inactivation of MEK1.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11684694     DOI: 10.1074/jbc.M109324200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  Regulation of extracellular signal-regulated kinase phosphorylation in cultured rat striatal neurons.

Authors:  Li-Min Mao; Qing-Song Tang; John Q Wang
Journal:  Brain Res Bull       Date:  2008-12-03       Impact factor: 4.077

Review 2.  Protein kinases and addiction.

Authors:  Anna M Lee; Robert O Messing
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

Review 3.  Vitamin D and differentiation in cancer.

Authors:  Elzbieta Gocek; George P Studzinski
Journal:  Crit Rev Clin Lab Sci       Date:  2009       Impact factor: 6.250

4.  Regulation of ERK Kinase by MEK1 Kinase Inhibition in the Brain.

Authors:  Tara C Tassin; David R Benavides; Florian Plattner; Akinori Nishi; James A Bibb
Journal:  J Biol Chem       Date:  2015-05-13       Impact factor: 5.157

5.  A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons.

Authors:  Ya-Li Zheng; Sashi Kesavapany; Maneth Gravell; Rebecca S Hamilton; Manfred Schubert; Niranjana Amin; Wayne Albers; Philip Grant; Harish C Pant
Journal:  EMBO J       Date:  2004-12-09       Impact factor: 11.598

6.  Microarray gene expression analysis of chemosensitivity for docetaxel, cisplatin and 5-fluorouracil (TPF) combined chemotherapeutic regimen in hypopharyngeal squamous cell carcinoma.

Authors:  Meng Lian; Haizhou Wang; Jugao Fang; Jie Zhai; Ru Wang; Xixi Shen; Yifan Yang; Zhihong Ma; Honggang Liu
Journal:  Chin J Cancer Res       Date:  2017-06       Impact factor: 5.087

7.  The Notch signaling inhibitor DAPT down-regulates cdk5 activity and modulates the distribution of neuronal cytoskeletal proteins.

Authors:  Jyotshnabala Kanungo; Ya-Li Zheng; Niranjana D Amin; Harish C Pant
Journal:  J Neurochem       Date:  2008-07-04       Impact factor: 5.372

8.  CB1R regulates CDK5 signaling and epigenetically controls Rac1 expression contributing to neurobehavioral abnormalities in mice postnatally exposed to ethanol.

Authors:  Vikram Joshi; Shivakumar Subbanna; Madhu Shivakumar; Balapal S Basavarajappa
Journal:  Neuropsychopharmacology       Date:  2018-08-22       Impact factor: 7.853

9.  Modeling cancer progression via pathway dependencies.

Authors:  Elena J Edelman; Justin Guinney; Jen-Tsan Chi; Phillip G Febbo; Sayan Mukherjee
Journal:  PLoS Comput Biol       Date:  2008-02       Impact factor: 4.475

10.  Identification of tyrosine hydroxylase as a physiological substrate for Cdk5.

Authors:  Janice W Kansy; S Colette Daubner; Akinori Nishi; Naoki Sotogaku; Michael D Lloyd; Chan Nguyen; Lin Lu; John W Haycock; Bruce T Hope; Paul F Fitzpatrick; James A Bibb
Journal:  J Neurochem       Date:  2004-10       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.